Rocket


News + Filings
Transactions
Holdings



BAY CITY CAPITAL LLC

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
12/03/2021MADRIGAL PHARMACEUTICALS, INC.MDGLOther (disposition)Common Stock750.3k$0.00$0See Footnotes12/03/2021
12/03/2021MADRIGAL PHARMACEUTICALS, INC.MDGLOther (disposition)Common Stock49.7k$0.00$0See Footnotes12/03/2021
12/03/2021MADRIGAL PHARMACEUTICALS, INC.MDGLOther (disposition)Common Stock24.2k$0.00$0 12/03/2021
10/26/2021Xilio Therapeutics, Inc. ConversionSeries C Preferred Stock1.4M$0.00$0See footnotes10/26/2021
10/26/2021Xilio Therapeutics, Inc. ConversionSeries B Preferred Stock6.3M$0.00$0See footnotes10/26/2021
10/26/2021Xilio Therapeutics, Inc. PurchaseCommon Stock312.5k$16.00$5MSee footnotes10/26/2021
10/26/2021Xilio Therapeutics, Inc. ConversionCommon Stock151.3k$0.00$0See footnotes10/26/2021
10/26/2021Xilio Therapeutics, Inc. ConversionCommon Stock665.7k$0.00$0See footnotes10/26/2021
12/01/2020MADRIGAL PHARMACEUTICALS, INC.MDGLOther (disposition)Common Stock43.5k$0.00$0See Footnotes12/01/2020
09/04/2020MADRIGAL PHARMACEUTICALS, INC.MDGLOther (acquisition)Common Stock1.5M$0.00$0See Footnotes09/04/2020
09/04/2020MADRIGAL PHARMACEUTICALS, INC.MDGLOther (acquisition)Common Stock31.6k$0.00$0See Footnotes09/04/2020
09/04/2020MADRIGAL PHARMACEUTICALS, INC.MDGLOther (acquisition)Common Stock45.5k$0.00$0 09/04/2020
08/19/2020MADRIGAL PHARMACEUTICALS, INC.MDGLSaleCommon Stock7.3k$107.64$786.1k 08/17/2020
08/18/2020MADRIGAL PHARMACEUTICALS, INC.MDGLSaleCommon Stock10.2k$110.03$1.1M 08/17/2020
08/17/2020MADRIGAL PHARMACEUTICALS, INC.MDGLSaleCommon Stock12.5k$110.73$1.4M 08/17/2020
05/27/2020MADRIGAL PHARMACEUTICALS, INC.MDGLOther (acquisition)Common Stock360.6k$0.00$0See Footnotes05/27/2020
05/27/2020MADRIGAL PHARMACEUTICALS, INC.MDGLOther (acquisition)Common Stock6.8k$0.00$0See Footnotes05/27/2020
05/27/2020MADRIGAL PHARMACEUTICALS, INC.MDGLOther (acquisition)Common Stock44.9k$0.00$0 05/27/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries B Preferred Stock16.1k$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAGrantStock Option (right to buy)15.5k$16.00$247.3k 03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionCommon Stock690.2k$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionCommon Stock13.1k$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries Seed Preferred Stock281.9k$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries Seed Preferred Stock5.4k$0.00$0(By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries A Preferred Stock3.2M$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries A Preferred Stock61.4k$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries B Preferred Stock845k$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
12/13/2019MADRIGAL PHARMACEUTICALS, INC.MDGLSaleCommon Stock25.3k$105.47$2.7MSee Footnote12/13/2019
12/13/2019MADRIGAL PHARMACEUTICALS, INC.MDGLSaleCommon Stock1.2M$105.47$123.9MSee Footnote12/13/2019
06/25/2018Kezar Life Sciences, Inc.KZRConversionCommon Stock472.2k$0.00$0See Footnotes06/25/2018
06/25/2018Kezar Life Sciences, Inc.KZRPurchaseCommon Stock150k$15.00$2.2MSee Footnotes06/25/2018
06/25/2018Kezar Life Sciences, Inc.KZRConversionSeries B Redeemable Convertible Preferred Stock472.2k$0.00$0See Footnotes06/25/2018
06/11/2018MADRIGAL PHARMACEUTICALS, INC.MDGLSaleCommon Stock274.1k$287.46$78.8MSee Footnotes06/11/2018
06/11/2018MADRIGAL PHARMACEUTICALS, INC.MDGLSaleCommon Stock5.9k$287.46$1.7MSee Footnotes06/11/2018
07/29/2016INTERLEUKIN GENETICS INCILIUPurchaseCommon Stock Warrant (right to buy)564.4k$0.10$56.1kSee footnotes07/29/2016
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy